S&P 500 Futures
(-0.76%) 5 068.75 points
Dow Jones Futures
(-0.27%) 38 576 points
Nasdaq Futures
(-1.35%) 17 426 points
Oil
(0.14%) $82.93
Gas
(-0.48%) $1.645
Gold
(-0.39%) $2 329.20
Silver
(-0.70%) $27.16
Platinum
(-0.51%) $911.10
USD/EUR
(-0.07%) $0.934
USD/NOK
(-0.09%) $10.97
USD/GBP
(-0.06%) $0.802
USD/RUB
(0.01%) $92.33

Realtime updates for Aspen Pharmacare Holdings [APNHY]

Exchange: OTC Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated24 Apr 2024 @ 12:58

-1.70% $ 10.98

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 12:58):

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments...

Stats
Today's Volume 1 840.00
Average Volume 141.00
Market Cap 4.88B
Last Dividend $0.184 ( 2023-09-21 )
Next Dividend $0 ( N/A )
P/E 19.26
ATR14 $0 (0.00%)

Aspen Pharmacare Holdings Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aspen Pharmacare Holdings Financials

Annual 2023
Revenue: $2.29B
Gross Profit: $1.02B (44.59 %)
EPS: $0.660
Q2 2024
Revenue: $1.13B
Gross Profit: $498.09M (44.05 %)
EPS: $0.280
Q4 2023
Revenue: $10.78B
Gross Profit: $4.95B (45.93 %)
EPS: $2.87
Q3 2023
Revenue: $10.78B
Gross Profit: $4.95B (45.93 %)
EPS: $2.87

Financial Reports:

No articles found.

Aspen Pharmacare Holdings Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.133
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0.184
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Aspen Pharmacare Holdings Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.17 - Stable (23.49%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.101 2010-10-06
Last Dividend $0.184 2023-09-21
Next Dividend $0 N/A
Payout Date 2023-10-11
Next Payout Date N/A
# dividends 12 --
Total Paid Out $2.03 --
Avg. Dividend % Per Year 0.00% --
Score 3.17 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 6.17
Div. Directional Score 9.50 --
Next Divdend (Est)
(2024-08-07)
$0.190 Estimate 3.02 %
Dividend Stability
0.24 Very Poor
Dividend Score
3.17
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SOMC Ex Dividend Knight 2023-07-13 Quarterly 0 0.00%
HEINY Ex Dividend Knight 2023-08-10 Annually 0 0.00%
ARTNB Ex Dividend Knight 2023-08-16 Quarterly 0 0.00%
NODB Ex Dividend Junior 2023-10-17 Quarterly 0 0.00%
DAIUF Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
THNPY Ex Dividend Knight 2023-05-18 Annually 0 0.00%
IFJPY Ex Dividend Junior 2023-08-10 Annually 0 0.00%
BHWB Ex Dividend Knight 2023-07-27 Quarterly 0 0.00%
PNGAY Ex Dividend Junior 2023-09-08 Semi-Annually 0 0.00%
EMSHF Ex Dividend Knight 2023-08-15 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1241.5007.5110.00[0 - 0.5]
returnOnAssetsTTM0.5271.20010.0010.00[0 - 0.3]
returnOnEquityTTM0.1611.5009.3310.00[0.1 - 1]
payoutRatioTTM0.203-1.0007.97-7.97[0 - 1]
currentRatioTTM1.9180.8005.414.33[1 - 3]
quickRatioTTM0.5450.800-1.500-1.200[0.8 - 2.5]
cashRatioTTM0.5051.5008.3010.00[0.2 - 2]
debtRatioTTM0.259-1.5005.68-8.52[0 - 0.6]
interestCoverageTTM62.301.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM10.802.006.4010.00[0 - 30]
freeCashFlowPerShareTTM6.382.006.8110.00[0 - 20]
debtEquityRatioTTM0.422-1.5008.31-10.00[0 - 2.5]
grossProfitMarginTTM0.4611.0005.645.64[0.2 - 0.8]
operatingProfitMarginTTM0.2241.0007.537.53[0.1 - 0.6]
cashFlowToDebtRatioTTM2.431.00010.0010.00[0.2 - 2]
assetTurnoverTTM4.240.80010.008.00[0.5 - 2]
Total Score12.83

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM23.651.0007.710[1 - 100]
returnOnEquityTTM0.1612.509.5710.00[0.1 - 1.5]
freeCashFlowPerShareTTM6.382.007.8710.00[0 - 30]
dividendYielPercentageTTM0.08611.5007.850[0 - 0.4]
operatingCashFlowPerShareTTM10.802.006.4010.00[0 - 30]
payoutRatioTTM0.2031.5007.97-7.97[0 - 1]
pegRatioTTM0.02511.500-3.170[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1491.0008.780[0.1 - 0.5]
Total Score6.17

Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators